XEMA Ukraine became a sponsor of Youth Symphonic Orchestra of Ukraine (YsOU)
XEMA launches GalMAg ELISA kit for detection of galactomannan in serum and broncoalveolar fluid- a powerful tool for diagnostics of invasive aspergillosis (cat# K021). Our kit has been tested in more than 500 clinical samples and shows good correlation to the reference test. The kit is available for customer evaluation and ordering
On March, 21-23 XEMA will welcome visitors at our booth B113 (Pavillion 3) at "MedExpo" fair, Ethiopia, Addis-Abeba.
XEMA exhibits for the first time at ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in Amsterdam, 13-16 April, booth Nr 1.106b. We show the results of clinical evaluation of GalMAg ELISA - detection of galactomannan for diagnostics of invasive aspergillosis, as well as ELISA and rapid tests for detection of other fungal antigens
XEMA exhibits for the first time at Arab Health exhibition, 28-31 January in Dubai World Trade Centre, within a national stand supported by Russian Export Center
We have obtained a set of monoclonal antibodies against the antigens of pistachio; the pilot versions of immunoassays (cat# K377 Pistachio ELISA and respective rapid test cat# X377 XEMAtest Pistachio are available for evaluation and ordering. The target of the assays were determined by WB and MALDI-TOF: allergen Pis v 2 2. Important feature for the assays is the absence of their cross-reactivity with closely related cashew antigens.
MA exhibits traditionally at major IVD event in China - CACLP , this time in NanChang Greenland International Expo Center, 22-24 March 2019, stand A3-S17
We have launched two new ELISA kits: Cat# K233 S100 ELISA applicable both as brain damage marker and tumor marker for melanoma and neuroblastoma Cat# K261 Calcitonin ELISA which also has two major application: monitoring of calcium metabolism and tumor marker for thyroid carcinoma as well as other tumors